"The U.S. Food and Drug Administration today approved Esbriet (pirfenidone) for the treatment of idiopathic pulmonary fibrosis (IPF).
Idiopathic pulmonary fibrosis is a condition in which the lungs become progressively scarred o"...
Surfaxin Patient Information Including Side Effects
Brand Names: Surfaxin
Generic Name: lucinactant (Pronunciation: loo SIN AK tant )
- What is lucinactant (Surfaxin)?
- What are the possible side effects of lucinactant (Surfaxin)?
- What is the most important information I should know about lucinactant (Surfaxin)?
- What should I discuss with my healthcare provider before treatment with lucinactant (Surfaxin)?
- How is lucinactant given (Surfaxin)?
- What happens if I miss a dose (Surfaxin)?
- What happens if I overdose (Surfaxin)?
- What should I avoid during treatment with lucinactant (Surfaxin)?
- What other drugs will affect lucinactant (Surfaxin)?
- Where can I get more information?
What is lucinactant (Surfaxin)?
Lucinactant is a lung surface acting agent, or "surfactant." It helps the lungs function normally. Lucinactant is similar to the natural fluid in the lungs that helps maintain effective breathing.
Lucinactant is used to treat or prevent respiratory distress syndrome (RDS) in a premature baby whose lungs have not fully developed.
Lucinactant may also be used for purposes not listed in this medication guide.
What are the possible side effects of lucinactant (Surfaxin)?
Lucinactant causes few side effects. There is a possibility that the baby will have breathing difficulties during the lucinactant treatment, and these problems may require further treatment by health care professionals. Your baby will remain under constant supervision during treatment with lucinactant.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Read the Surfaxin (lucinactant) Side Effects Center for a complete guide to possible side effects
What is the most important information I should know about lucinactant (Surfaxin)?
Your baby will receive this medication in a neonatal intensive care unit (NICU) or similar hospital setting.
Lucinactant is given directly into the baby's lungs through a breathing tube that is also connected to a ventilator (a machine that moves air in and out of the lungs to help your baby breathe easier and get enough oxygen).
Your baby will remain under constant supervision during treatment with lucinactant.
Additional Surfaxin Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.